Product Name: MARK2 (19-37)
Product Number: PE-01BDR80
| Size: | 200 µg | Price: | 48.00 | |
| 1 mg | $US | 96.00 | ||
| 5 mg | 208.00 |
Peptide Name: MARK2 (19-37)
Product Use: Services as a blocking peptide for use with the MARK2-ANT rabbit polyclonal antibody (Cat. No.: AB-NK275-1) that is also available from Kinexus. The peptide sequence is located in the post-N-terminus.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: PTLGHLDSKPSSKSNMIRGC
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 2127.4 Da
Peptide Purity Percent after Synthesis and Purification: >80
Product Use: Services as a blocking peptide for use with the MARK2-ANT rabbit polyclonal antibody (Cat. No.: AB-NK275-1) that is also available from Kinexus. The peptide sequence is located in the post-N-terminus.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: PTLGHLDSKPSSKSNMIRGC
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 2127.4 Da
Peptide Purity Percent after Synthesis and Purification: >80
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Related Product 1: MARK2 pan-specific antibody (Cat. No.: AB-NK275-1)
Peptide Form: Solid
Storage Conditions: -20°C
Related Product 1: MARK2 pan-specific antibody (Cat. No.: AB-NK275-1)
Scientific Background: MARK2 is a protein-serine/threonine kinase of the CAMK group and CAMKL family. It is activated by phosphorylation on T208 by STK11 in complex with STE20-related adapter-alpha (STRAD alpha) pseudo kinase and CAB39. It mediates cell polarity and microtubule function. Some substrate proteins that MARK2 phosphorylates include CRTC2/TORC2, HDAC7, DCX, KIF13B, MAPT/TAU, MAP2, MAP4, and RAB11FIP2. Phosphorylation of microtubule associated proteins leads to protein dissociation and microtubule degeneration. The phosphorylation of MARK2 by the LKB1/LKB1 complex can occur with a T208A mutation in MARK2. The ability of MARK2 to bind YWHAZ and to dissociate from the membrane occurs with a T596A mutation. Inhibition of MARK2 via small inhibitory RNA induced axon-like outgrowth from neurites.
© Kinexus Bioinformatics Corporation 2017